Laboratory Test Preparation

| Test | : | Strongyloides Antibody |
| Other Test Request Name | : | Strongyloidiasis Serology |
| Test Composition | : | Not applicable |
| Intended Use | : | A tropical infection due to the parasite Strongyloides stercoralis. Sometimes occurs in humid temperate regions. This test is usually performed when a subject who has recently visited an endemic area presents with recurrent gastrointestinal problems associated with pruritis and eosinophilia. Diagnosis relies on the identification of larvae in fresh stools. Serological results are often difficult to interpret because of the many possible cross reactions, mostly with other nematodes. |
| Methodology | : | Enzyme Immunoassay (EIA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday, 4:00 PM |
| TAT/Releasing of Results | : | 3 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Strongyloides stercoralis, infective filariform larva in warm, moist soil |
| Test | : | Sucrose (FOR HP DEL MONTE ONLY) |
| Other Test Request Name | : | Sucrose Hemolysis Test |
| Test Composition | : | Not Applicable |
| Intended Use | : | The Sucrose Hemolysis Test is useful in screening for paroxysmal nocturnal hemoglobinuria (PNH). PNH describes erythrocytic destruction with the appearance of dark urine in the morning. PNH is an acquired disorder that is characterized by hemolytic anemia, large vessel thrombosis, or a deficiency of hematopoiesis. |
| Methodology | : | Hemolysis |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Citrated or Blue Top |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 2 pcs of 4mL Citrated whole blood |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 2 Hours |
| • Refrigerated Temperature (2-8°C) | : | Not Applicable |
| • Freezer Temperature (-20°C) | : | Not Applicable |
| Transport Temperature | : | Transport specimen at 15°C ~25 °C (room temperature) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | 3 days after running (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified. |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Carbohydrate, Sugar |
| Test | : | Surgical Pathology Test |
| Other Test Request Name | : |
|
| Test Composition | : |
|
| Intended Use | : |
|
| Methodology | : |
|
| Laboratory Section | : |
|
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : |
|
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : |
|
| Alternative Specimen and Volume Requirement | : |
|
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : |
|
| • Refrigerated Temperature (2-8°C) | : |
|
| • Freezer Temperature (-20°C) | : |
|
| Transport Temperature | : |
|
| Rejection Criteria | : |
|
| Running Day | : |
|
| Cut Off Time | : |
|
| TAT/Releasing of Results | : |
|
| Reference Interval/Result Interpretation | : |
|
| Limitations/Interferences | : |
|
| Frequently Asked Questions (FAQs) | : |
|
| Related Words/Test | : |
|
| Test | : | Synaptophysin |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | Not applicable |
| Intended Use | : | It is used to differentiate carcinoid from carcinoma; merkel cell carcinoma vs. basal cell carcinoma; small cell carcinoma of lung vs. lymphoma |
| Methodology | : | Precipitation Indirect Reaction |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Slide holders or mailers for microscope slides; FFPE tissue blocks can either be wrapped in paper or placed in a box. |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | • Formalin-fixed paraffin-embedded (FFPE) tissue block |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Indefinite |
| • Refrigerated Temperature (2-8°C) | : | Not applicable |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | • Microscope slides should be placed in slide holders or mailers and should be adequately padded before placing in a shipping/packaging container to prevent breakage. |
| Rejection Criteria | : | • Incomplete information in the Request Form |
| Running Day | : | Tuesday , Thursday and Saturday |
| Cut Off Time | : | Monday, Wednesday and Friday 3:00 P.M |
| TAT/Releasing of Results | : | After 7 days (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Major synaptic vesicle protein p38 |
| Test | : | Synovial Fluid Analysis |
| Other Test Request Name | : | • Joint Fluid Analysis |
| Test Composition | : | 1. Macroscopic |
| Intended Use | : | • Cell Count and Differential Count: Cell count and identification of types of cells present are used in determining the cause of an effusion, especially when used in combination with an individual's medical history, physical examination and other tests performed. |
| Methodology | : | • WBC count- Fluorescent Cytometry |
| Laboratory Section | : | • Cell Count/Differential Count: Hematology |
| Special Instructions/Patient Preparations | : | • Cell Count/Diff Count: No patient preparation necessary |
| Collection/Sample Container | : | Glucose and Protein: |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | • Cell Count/Diff Count: 3-5 mL |
| Alternative Specimen and Volume Requirement | : | Not applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Glucose and Protein: 1 Day |
| • Refrigerated Temperature (2-8°C) | : | Glucose and Protein: 6 Days |
| • Freezer Temperature (-20°C) | : | Unacceptable |
| Transport Temperature | : | Transport specimen at 15–25 °C (room temperature) |
| Rejection Criteria | : | • Quantity not sufficient |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday: 10:00 PM |
| TAT/Releasing of Results | : | ROUTINE |
| Reference Interval/Result Interpretation | : | Glucose: |
| Limitations/Interferences | : | None specified |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Uric Acid, Gram Stain, Susceptibility Testing, AFB Testing, Body Fluid Analysis, Rheumatoid Factor, Cyclic Citrullinated Peptide Antibody |
| Test | : | T. Calcium (COLORIMETRIC) |
| Other Test Request Name | : | • Total Calcium |
| Test Composition | : | Not applicable |
| Intended Use | : | • Used to screen for, diagnose, and monitor a range of conditions relating to the bones, heart, nerves, kidneys, and teeth. |
| Methodology | : | Colorimetric |
| Laboratory Section | : | Chemistry |
| Special Instructions/Patient Preparations | : | • 8-12 hours fasting. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3 mL Plasma (Li-Heparin) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 7 Days |
| • Refrigerated Temperature (2-8°C) | : | 3 Weeks |
| • Freezer Temperature (-20°C) | : | 8 Months |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday:6:00 PM |
| TAT/Releasing of Results | : | RUNNING TIME: 6:00 AM onwards RELEASING TIME: ROUTINE |
| Reference Interval/Result Interpretation | : | 2.10-2.55 mmol/L (8.40-10.20 mg/dL) |
| Limitations/Interferences | : | • Blood from patients receiving Hypaque radiographic contrast agent cannot be used. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Phosphorus, Vitamin D Tests, PTH, Magnesium, Albumin, Comprehensive Metabolic Panel, Basic Metabolic Panel, Kidney Stone Analysis, Kidney Stone Risk Panel |
| Test | : | T. gondii IgM (Quali) -TEMPORARILY UNAVAILABLE |
| Other Test Request Name | : | Toxoplasma gondii Quali IgM |
| Test Composition | : | Not Applicable |
| Intended Use | : | Used for Qualitative detection of IgM antibodies to Toxoplasma gondii, used as screening for toxoplasmosis. |
| Methodology | : | Immunochromatography |
| Laboratory Section | : | Serology |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-2mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-2mL Plasma (EDTA) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Specified |
| • Refrigerated Temperature (2-8°C) | : | 3 Days |
| • Freezer Temperature (-20°C) | : | >3 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Improperly labeled specimens |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday |
| TAT/Releasing of Results | : | ROUTINE |
| Reference Interval/Result Interpretation | : | NEGATIVE |
| Limitations/Interferences | : | None identified. |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Newborn Infection, Toxoplasmosis, Toxoplasma gondii Antibodies, IgG, IgM; Toxoplasma gondii Molecular Detection by PCR |
| Test | : | T. Protein (COLORIMETRIC) |
| Other Test Request Name | : | • TP |
| Test Composition | : | Not applicable |
| Intended Use | : | • May be used for evaluation of nutritional status and protein altering diseases like kidney disease or liver disease |
| Methodology | : | Colorimetric |
| Laboratory Section | : | Chemistry |
| Special Instructions/Patient Preparations | : | • No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3 mL Plasma (Li- or Na-Heparin) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 1 Week |
| • Refrigerated Temperature (2-8°C) | : | 34 Days |
| • Freezer Temperature (-20°C) | : | 2 Months |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday: 6:00 PM Sunday: 4:00PM |
| TAT/Releasing of Results | : | RUNNING TIME: 6:00 AM onwards RELEASING TIME: ROUTINE |
| Reference Interval/Result Interpretation | : | 0-3Y: 59.00-70.00 g/L (5.90-7.00 g/dL) |
| Limitations/Interferences | : | Interferences from medications or endogenous substances may affect results. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Albumin, Liver Panel, Protein Electrophoresis, Comprehensive Metabolic Panel, BUN, Creatinine, Urine Protein, Body Fluid Analysis |
| Test | : | T3 (ECLIA) |
| Other Test Request Name | : | • Triiodothyronine |
| Test Composition | : | Not applicable |
| Intended Use | : | The determination of T3 is utilized in the diagnosis of T3-hyperthyoridism , the detection of early stages of hyperthyroidism and for indicating a diagnosis of thyrotoxicosis factitia. |
| Methodology | : | Electrochemiluminescence Immunoassay (ECLIA) |
| Laboratory Section | : | Immunology |
| Special Instructions/Patient Preparations | : | Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3 mL Plasma (Li-, Na-, NH4 -heparin, K3-EDTA, Sodium Citrate, Sodium Fluoride, Potassium Oxalate) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not specified |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 1 Month (Freeze only once) |
| Transport Temperature | : | Transport specimen at 2°C – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Monday, Tuesday, Wednesday, Thursday, Friday, Saturday |
| Cut Off Time | : | Monday to Saturday:10:00 PM Sunday:6:00PM |
| TAT/Releasing of Results | : | ROUTINE (on running days) |
| Reference Interval/Result Interpretation | : | 1.30-3.10 nmol/L |
| Limitations/Interferences | : | • Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Thyroid Function Test, TSH; Free T4; Thyroid Panel; Thyroid Antibodies |
| Test | : | T3 Reverse (RIA) |
| Other Test Request Name | : |
|
| Test Composition | : | Not applicable |
| Intended Use | : | The assay may be useful in the diagnosis of nonthyroidal illness (NTI). Patients with NTI have low T3 concentrations and increased concentrations of rT3. RT3 may be useful in neonates to distinguish euthyroid sick syndrome from central hypothyroidism. Mainly produced by the deiodination of thyroxine (T4) in peripheral tissue. |
| Methodology | : | Radioimmunoassay (RIA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday, 4:00 PM |
| TAT/Releasing of Results | : | 3 months after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Isomer of triiodothyronine |
| Test | : | T4 (ECLIA) |
| Other Test Request Name | : | • Thyroxine |
| Test Composition | : | Not applicable |
| Intended Use | : | The determination of T4 can be utilized for the detection of primary and secondary hypothyroidism and for monitoring of TSH-supression therapy. |
| Methodology | : | Electrochemiluminescence Immunoassay (ECLIA) |
| Laboratory Section | : | Immunology |
| Special Instructions/Patient Preparations | : | • Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3 mL Plasma (Li-, Na?heparin and K3?EDTA) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not specified |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 1 Month (Freeze only once) |
| Transport Temperature | : | Transport specimen at 2°C – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Monday, Tuesday, Wednesday, Thursday, Friday, Saturday |
| Cut Off Time | : | Monday to Saturday:10:00 PM Sunday:6:00PM |
| TAT/Releasing of Results | : | ROUTINE (on running days) |
| Reference Interval/Result Interpretation | : | 66.00-181.00 nmol/L |
| Limitations/Interferences | : | • Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Thyroid Function Test, TSH, Free T3 or Total T3, Thyroid Panel, Thyroid Antibodies, Calcitonin, Free T4 |
| Test | : | Tacrolimus (ECLIA) |
| Other Test Request Name | : |
|
| Test Composition | : | Not applicable |
| Intended Use | : | To monitor the adequacy of drug dosage levels in management of immunosuppression for organ transplant recipients. |
| Methodology | : | Electrochemiluminescence Immunoassay (ECLIA) |
| Laboratory Section | : | Immunology |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | EDTA |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 2mL EDTA whole blood (K2- or K3- EDTA only) |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 5 Days |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 6 Months |
| Transport Temperature | : | Transport specimen at 2°C – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Saturday: 12:00 PM |
| Cut Off Time | : | Monday to Saturday: 6:00 PM |
| TAT/Releasing of Results | : | ROUTINE (on running days)
STAT (on running days only)
|
| Reference Interval/Result Interpretation | : | 5.00~20.00 ng/mL NOTE: No firm therapeutic range exists for tacrolimus in whole blood. The complexity of the clinical state, individual differences in sensitivity to immunosuppressive and nephrotoxic effects of tacrolimus, coadministration of other immunosuppressants, type of transplant, time post-transplant, and a number of other factors contribute to different requirements for optimal blood levels of tacrolimus. Individual tacrolimus values cannot be used as the sole indicator for making changes in the treatment regimen. Each patient should be thoroughly evaluated clinically before treatment adjustments are made, and each assay user must establish his or her ranges based on clinical experience. |
| Limitations/Interferences | : |
|
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Organ Transplant, Immuno suppressant, Immuno suppressant agent |
| Test | : | Tamoxifen and Metabolites |
| Other Test Request Name | : | • Tamoxifen • Endoxifen • N-Desmethyl Tamoxifen • 4-Hydroxy Tamoxifen • N-Desmethyl-4'-Hydroxy Tam • 4'-Hydroxy Tamoxifen) |
| Test Composition | : | Not applicable |
| Intended Use | : | Tamoxifen is a prodrug and undergoes biotransformation into a series of metabolites. N-desmethyl tamoxifen is the most abundant metabolite. 4-Hydroxy tamoxifen and N-desmethyl-4-hydroxy tamoxifen (endoxifen) are the most potent metabolites. Studies have shown that genetic variations in the CYP2D6 enzymes influence endoxifen levels. Due to this variability, monitoring endoxifen levels and phase one metabolite rather than CYP2D6 genotype testing is suggested to be a better approach for monitoring tamoxifen therapy. |
| Methodology | : | Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red tube (DO NOT USE GOLD TUBE or any other type of tube with gel separator) |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 7 Days |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen • Markedly lipemic specimen • Exceeded sample stability requirement • Quantity not sufficient • Improperly labeled specimen • Improper collection tube used |
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday 4:00 PM |
| TAT/Releasing of Results | : | 14 days after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Nolvadex, medication that is used to prevent breast cancer in women |
| Test | : | TB C/S |
| Other Test Request Name | : |
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Tuberculosis is a chronic, granulomatous disease caused by M. tuberculosis. Identification, and, if appropriate, antibiotic sensitivity, is required to initiate necessary therapy. TB is an infectious bacterial disease caused by mycobacterium tuberculosis, which most commonly affects the lungs. |
| Methodology | : | Bactec MGIT |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
Note:
1. Expectorated Sputum
C. Pleural Effusion
D. Urine
|
| Collection/Sample Container | : | Plastic leak proof sterile container (screw cap) NOTE:Sample must be properly packed (trtiple packaging) |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : |
|
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | SPUTUM- 24 Hours URINE- 24 Hours OTHER BODY FLUIDS- 7 Days |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimen at 2°C - 8°C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM
For Sputum Samplemust be at Laboratory, Monday to Friday before 7:00 AM., sample must be collected Monday to Thursday, on or before 3:00 PM and need to be send to MAIN branch within that day. |
| TAT/Releasing of Results | : | 3 months after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Bacteria or fungi that are causing an infection of the lungs |
| Test | : | TB PCR (BY APPOINTMENT) |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | Not applicable |
| Intended Use | : | Used to aid the physician in the rapid diagnosis and treatment of a possible tuberculosis infection. |
| Methodology | : | Polymerase Chain Reaction (PCR) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
NOTE: Do not collect specimen without approval of Special Test Section
|
| Collection/Sample Container | : | Plastic leak proof sterile container (screw cap) NOTE: Sample must be properly packed (trtiple packaging)
|
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | Atleast 2 mL Sputum |
| Alternative Specimen and Volume Requirement | : | Atleast 2 mL Any body fluids or 60 mL Random Urine |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 5 Days |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimen at 2°C - 8°C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Wednesday |
| Cut Off Time | : | Tuesday, 7:00 AM |
| TAT/Releasing of Results | : | 3 days after running day (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Confirm an infection of Tuberculosis |